143 related articles for article (PubMed ID: 36415258)
1. Clinical efficacy of neoadjuvant chemohormonal therapy combined with laparoscopic radical prostatectomy in high-risk Prostate Cancer.
Zhang P; Cai S; Yan C; Li L
Pak J Med Sci; 2022; 38(8):2076-2082. PubMed ID: 36415258
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemohormonal therapy combined with radical prostatectomy and extended PLND for very high risk locally advanced prostate cancer: A retrospective comparative study.
Pan J; Chi C; Qian H; Zhu Y; Shao X; Sha J; Xu F; Wang Y; Karnes RJ; Dong B; Xue W
Urol Oncol; 2019 Dec; 37(12):991-998. PubMed ID: 31466813
[TBL] [Abstract][Full Text] [Related]
3. Radical Prostatectomy With and Without Neoadjuvant Chemohormonal Pretreatment for High-Risk Localized Prostate Cancer: A Comparative Propensity Score Matched Analysis.
Narita S; Nara T; Kanda S; Numakura K; Saito M; Inoue T; Satoh S; Nanjo H; Tsuchiya N; Mitsuzuka K; Koie T; Kawamura S; Ohyama C; Tochigi T; Arai Y; Habuchi T
Clin Genitourin Cancer; 2019 Feb; 17(1):e113-e122. PubMed ID: 30391137
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Neoadjuvant Chemohormonal Therapy in Oligometastatic Hormone-Sensitive Prostate Cancer: A Prospective, Three-Arm, Comparative Propensity Score Match Analysis.
Chi C; Fan L; Dong B; Zhu Y; Xin Z; Pan J; Xue W
Clin Genitourin Cancer; 2021 Aug; 19(4):e223-e234. PubMed ID: 33824096
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemohormonal therapy before radical prostatectomy in high-risk prostate cancer: a mini-review.
Fan J; Jiang Z; Wang G; He D; Wu K
Am J Clin Exp Urol; 2024; 12(1):1-7. PubMed ID: 38500864
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant Chemohormonal Therapy before Radical Prostatectomy for Japanese Patients with High-Risk Localized Prostate Cancer.
Sasaki T; Nishikawa K; Kato M; Masui S; Yoshio Y; Sugimura Y; Inoue T
Med Sci (Basel); 2021 Apr; 9(2):. PubMed ID: 33918590
[TBL] [Abstract][Full Text] [Related]
7. Predictive factors associated with differential pathologic response to neoadjuvant chemohormonal therapy in high-risk localized prostate cancer.
Fan J; Liang H; Gu Y; Jiang Z; Jiang F; Wang Y; He D; Wu K
Urol Oncol; 2023 Aug; 41(8):354.e1-354.e9. PubMed ID: 37295981
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant Chemohormonal Therapy in Prostate Cancer Before Radical Prostatectomy: A Systematic Review and Meta-Analysis.
Ge Q; Xu H; Yue D; Fan Z; Chen Z; Xu J; Zhou Y; Zhang S; Xue J; Shen B; Wei Z
Front Oncol; 2022; 12():906370. PubMed ID: 35646683
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Neoadjuvant Luteinizing Hormone-Releasing Hormone Antagonist and Tegafur-Uracil Chemohormonal Therapy for High-Risk Prostate Cancer.
Sugino F; Nakane K; Kawase M; Ueda S; Tomioka M; Takeuchi Y; Tomioka-Inagawa R; Yamada T; Namiki S; Kumada N; Takeuchi S; Kawase K; Kato D; Takai M; Iinuma K; Tobisawa Y; Koie T
Life (Basel); 2023 Apr; 13(5):. PubMed ID: 37240717
[TBL] [Abstract][Full Text] [Related]
10. Short-term clinicopathological outcome of neoadjuvant chemohormonal therapy comprising complete androgen blockade, followed by treatment with docetaxel and estramustine phosphate before radical prostatectomy in Japanese patients with high-risk localized prostate cancer.
Narita S; Tsuchiya N; Kumazawa T; Maita S; Numakura K; Obara T; Tsuruta H; Saito M; Inoue T; Horikawa Y; Satoh S; Nanjyo H; Habuchi T
World J Surg Oncol; 2012 Jan; 10():1. PubMed ID: 22214417
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of a neoadjuvant chemohormonal taxane-based phase II trial before radical prostatectomy in patients with non-metastatic high-risk prostate cancer.
Prayer-Galetti T; Sacco E; Pagano F; Gardiman M; Cisternino A; Betto G; Sperandio P
BJU Int; 2007 Aug; 100(2):274-80. PubMed ID: 17355369
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemohormonal therapy followed by robot-assisted and minimum incision endoscopic radical prostatectomy in patients with high-risk prostate cancer: comparison of perioperative and oncological outcomes at single institution.
Fujita N; Koie T; Hashimoto Y; Narita T; Tobisawa Y; Tanaka T; Noro D; Oikawa M; Hagiwara K; Yoneyama T; Imai A; Yamamoto H; Hatakeyama S; Yoneyama T; Ohyama C
Int Urol Nephrol; 2018 Nov; 50(11):1999-2005. PubMed ID: 30229466
[TBL] [Abstract][Full Text] [Related]
13. Overall survival of high-risk prostate cancer patients who received neoadjuvant chemohormonal therapy followed by radical prostatectomy at a single institution.
Fujita N; Koie T; Ohyama C; Tanaka Y; Soma O; Matsumoto T; Yamamoto H; Imai A; Tobisawa Y; Yoneyama T; Hatakeyama S; Hashimoto Y
Int J Clin Oncol; 2017 Dec; 22(6):1087-1093. PubMed ID: 28681153
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of radical prostatectomy after neoadjuvant chemohormonal therapy for patients with high risk or locally advanced prostate cancer: results of a phase I/II study.
Konety BR; Eastham JA; Reuter VE; Scardino PT; Donat SM; Dalbagni G; Russo P; Herr HW; Schwartz L; Kantoff PW; Scher H; Kelly WK
J Urol; 2004 Feb; 171(2 Pt 1):709-13. PubMed ID: 14713792
[TBL] [Abstract][Full Text] [Related]
15. [Functional outcomes of transvesical single-site versus extraperitoneal laparoscopic radical prostatectomy for low-risk prostate cancer].
Liu S; Wen XQ
Zhonghua Nan Ke Xue; 2014 Nov; 20(11):1012-9. PubMed ID: 25577838
[TBL] [Abstract][Full Text] [Related]
16. Laparoscopic and robotic-assisted versus open radical prostatectomy for the treatment of localised prostate cancer.
Ilic D; Evans SM; Allan CA; Jung JH; Murphy D; Frydenberg M
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD009625. PubMed ID: 28895658
[TBL] [Abstract][Full Text] [Related]
17. [Perioperative parameters and prognosis analysis of patients aged 80 years or older treated with radical prostatectomy for prostate cancer].
Zhang F; Zhang SD; Xiao CL; Huang Y; Ma LL
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Oct; 50(5):822-827. PubMed ID: 30337742
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness comparison between neoadjuvant chemohormonal therapy and extended pelvic lymph node dissection in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysis.
Matsumoto T; Hatakeyama S; Ookubo T; Mitsuzuka K; Narita S; Inoue T; Yamashita S; Narita T; Koie T; Kawamura S; Tochigi T; Tsuchiya N; Habuchi T; Arai Y; Ohyama C
Med Oncol; 2017 Oct; 34(12):190. PubMed ID: 29090390
[TBL] [Abstract][Full Text] [Related]
19. Long-term results of a phase II study with neoadjuvant docetaxel chemotherapy and complete androgen blockade in locally advanced and high-risk prostate cancer.
Thalgott M; Horn T; Heck MM; Maurer T; Eiber M; Retz M; Autenrieth M; Herkommer K; Krause BJ; Gschwend JE; Treiber U; Kübler HR
J Hematol Oncol; 2014 Mar; 7():20. PubMed ID: 24598155
[TBL] [Abstract][Full Text] [Related]
20. Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(27):1-118. PubMed ID: 23074405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
